Edwards Lifesciences
Stock Forecast, Prediction & Price Target

Edwards Lifesciences (EW) stock Price Target by analysts

Last Year
Average Price Target

$74.15

Potential downside: -7.58%

Based on 11 analysts

Edwards Lifesciences price prediction

Strike.market

What is Edwards Lifesciences stock analysts` prediction?

Edwards Lifesciences stock forecast: Based on 11 Wall Street analysts` predicted price targets for Edwards Lifesciences in the last 3 months, the avarage price target is $74.15, with a high forecast of $NaN. The average price target represents a -7.58% change from the last price of $80.24.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Edwards Lifesciences stock Price Target by analysts

Full breakdown of analysts given Edwards Lifesciences price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
William Plovanic
Canaccord Genuity
0%
0/2
9 months ago $68 -15.25% downside $73.26 StreetInsider
Previous targets (1)
Richard Newitter
Truist Financial
0%
0/4
9 months ago $78 -2.79% downside $72.64 StreetInsider
Previous targets (3)
Lee Hambright
Bernstein
0%
0/1
9 months ago $72 -10.26% downside $72.63 StreetInsider
Previous targets (0)
David Roman
Goldman Sachs
0%
0/2
10 months ago $80 -0.29% downside $68.63 StreetInsider
Previous targets (1)
Travis Steed
Bank of America Securities
0%
0/2
10 months ago $75 -6.53% downside $68.63 StreetInsider
Previous targets (1)
Joanne Wuensch
Citigroup
0%
0/1
10 months ago $81 0.94% upside $69.05 TheFly
Previous targets (0)
David Rescott
Robert W. Baird
0%
0/1
11 months ago $73 -9.02% downside $69.63 StreetInsider
Previous targets (0)
Patrick Wood
Morgan Stanley
0%
0/1
11 months ago $70 -12.76% downside $68.26 TheFly
Previous targets (0)
William Plovanic
Canaccord Genuity
0%
0/2
11 months ago $66 -17.74% downside $65.49 TheFly
Previous targets (1)
Matthew Taylor
Jefferies
0%
0/1
12 months ago $70 -12.76% downside $67.23 StreetInsider
Previous targets (0)
Richard Newitter
Truist Financial
0%
0/4
12 months ago $71 -11.51% downside $68.13 StreetInsider
Previous targets (3)
Matt Miksic
Barclays
0%
0/1
12 months ago $80 -0.29% downside $66.81 TheFly
Previous targets (0)
Larry Biegelsen
Wells Fargo
0%
0/2
12 months ago $80 -0.29% downside $66.81 TheFly
Previous targets (1)
Narumi Nakagiri
Daiwa
0%
0/1
about 1 year ago $72 -10.26% downside $63.64 StreetInsider
Previous targets (0)
Joanna Wuensch
Citigroup
0%
0/1
about 1 year ago $83 3.43% upside $63.74 StreetInsider
Previous targets (0)
Rick Wise
Stifel Nicolaus
66.67%
2/3
about 1 year ago $70 -12.76% downside $86.95 TheFly
Previous targets (2)
Pito Chickering
Deutsche Bank
33.33%
1/3
about 1 year ago $85 5.93% upside $60.58 Benzinga
Previous targets (2)
Adam Maeder
Piper Sandler
0%
0/1
about 1 year ago $73 -9.02% downside $86.95 TheFly
Previous targets (0)
Suraj Kalia
Oppenheimer
0%
0/3
about 1 year ago $90 12.16% upside $60.58 Benzinga
Previous targets (2)
Shagun Singh
RBC Capital
0%
0/2
about 1 year ago $85 5.93% upside $60.58 Benzinga
Previous targets (1)
Robbie Marcus
J.P. Morgan
0%
0/2
about 1 year ago $72 -10.26% downside $60.58 Benzinga
Previous targets (1)
Richard Newitter
Truist Financial
0%
0/4
about 1 year ago $110 37.08% upside $89.5 TheFly
Previous targets (3)
David Roman
Goldman Sachs
0%
0/2
over 1 year ago $107 33.34% upside $87.03 StreetInsider
Previous targets (1)
Pito Chickering
Deutsche Bank
33.33%
1/3
over 1 year ago $103 28.36% upside $84.7 StreetInsider
Previous targets (2)
Shagun Singh
RBC Capital
0%
0/2
over 1 year ago $101 25.87% upside $90.28 TheFly
Previous targets (1)
Anthony Petrone
Mizuho Securities
0%
0/1
over 1 year ago $105 30.85% upside $91.51 TheFly
Previous targets (0)
Suraj Kalia
Oppenheimer
0%
0/3
over 1 year ago $100 24.62% upside $92.85 StreetInsider
Previous targets (2)
Unknown
Canaccord Genuity
N/A
over 2 years ago $76 -5.28% downside $78.21 Benzinga
N/A
Unknown
Truist Financial
N/A
over 2 years ago $86 7.17% upside $76.7 Benzinga
N/A
Unknown
Morgan Stanley
N/A
over 2 years ago $95 18.39% upside $76.32 Benzinga
N/A
Unknown
Raymond James
N/A
over 2 years ago $83 3.43% upside $75.32 Benzinga
N/A
Unknown
Citigroup
N/A
over 2 years ago $92 14.65% upside $75.26 Benzinga
N/A
Rick Wise
Stifel Nicolaus
66.67%
2/3
over 2 years ago $75 -6.53% downside $73.85 TheFly
Previous targets (2)
Unknown
RBC Capital
N/A
almost 3 years ago $105 30.85% upside $75.98 Benzinga
N/A
Shagun Singh Chadha
RBC Capital
0%
0/1
almost 3 years ago $118 47.05% upside $70.87 StreetInsider
Previous targets (0)
Richard Newitter
Truist Financial
0%
0/4
about 3 years ago $120 49.55% upside $100.54 Pulse 2.0
Previous targets (3)
Unknown
RBC Capital
N/A
over 3 years ago $135 68.24% upside $116.27 Benzinga
N/A
Unknown
Leerink Partners
N/A
over 3 years ago $138 71.98% upside $116.27 Benzinga
N/A
Unknown
Raymond James
N/A
over 3 years ago $124 54.53% upside $111.87 Benzinga
N/A
Unknown
Canaccord Genuity
N/A
over 3 years ago $137 70.73% upside $111.59 Benzinga
N/A
Vijay Kumar
Evercore ISI
100%
1/1
over 3 years ago $126 57.02% upside $120.36 Pulse 2.0
Previous targets (0)
Travis Steed
Bank of America Securities
0%
0/2
over 3 years ago $130 62.01% upside $111.98 Pulse 2.0
Previous targets (1)
Rick Wise
Stifel Nicolaus
66.67%
2/3
over 3 years ago $120 49.55% upside $101.96 StreetInsider
Previous targets (2)
Danielle Antalffy
Leerink Partners
0%
0/1
over 3 years ago $130 62.01% upside $101.96 TipRanks Contributor
Previous targets (0)
Cecilia Furlong
Morgan Stanley
0%
0/1
over 3 years ago $136 69.49% upside $101.96 TipRanks Contributor
Previous targets (0)
Pito Chickering
Deutsche Bank
33.33%
1/3
over 3 years ago $113 40.82% upside $108.63 TipRanks Contributor
Previous targets (2)
Matt Miksic
Credit Suisse
0%
0/1
over 3 years ago $140 74.47% upside $122.3 TheFly
Previous targets (0)
Robbie Marcus
J.P. Morgan
0%
0/2
over 3 years ago $140 74.47% upside $122.12 TheFly
Previous targets (1)
Suraj Kalia
Oppenheimer
0%
0/3
over 3 years ago $135 68.24% upside $120.34 StreetInsider
Previous targets (2)
Larry Biegelsen
Wells Fargo
0%
0/2
over 3 years ago $133 65.75% upside $120.34 TheFly
Previous targets (1)

Edwards Lifesciences Financial Estimates

Edwards Lifesciences Revenue Estimates

Edwards Lifesciences EBITDA Estimates

Edwards Lifesciences Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$5.23B
 
N/A
$5.38B
 
2.86%
$6.00B
 
11.56%
Avg: $7.20B
Low: $7.11B
High: $7.32B
avg. 20.03%
Avg: $7.90B
Low: $7.50B
High: $8.01B
avg. 9.60%
Avg: $8.67B
Low: $8.24B
High: $8.80B
avg. 9.84%
Avg: $9.38B
Low: $8.92B
High: $9.52B
avg. 8.17%
Net Income
 
% change YoY
$1.50B
 
N/A
$1.52B
 
1.25%
$1.40B
 
-7.85%
Avg: $1.87B
Low: $1.73B
High: $2.09B
avg. 34.01%
Avg: $2.05B
Low: $1.85B
High: $2.24B
avg. 9.21%
Avg: $2.41B
Low: $2.25B
High: $2.46B
avg. 17.64%
Avg: $2.68B
Low: $2.50B
High: $2.73B
avg. 10.99%
EBITDA
 
% change YoY
$1.48B
 
N/A
$1.82B
 
23.36%
$1.76B
 
-3.40%
Avg: $2.37B
Low: $2.34B
High: $2.41B
avg. 34.49%
Avg: $2.60B
Low: $2.47B
High: $2.64B
avg. 9.60%
Avg: $2.86B
Low: $2.71B
High: $2.90B
avg. 9.84%
Avg: $3.09B
Low: $2.94B
High: $3.14B
avg. 8.17%
EPS
 
% change YoY
$2.41
 
N/A
$2.46
 
2.07%
$2.31
 
-6.09%
Avg: $3.11
Low: $2.85
High: $3.43
avg. 34.46%
Avg: $3.37
Low: $3.05
High: $3.69
avg. 8.57%
Avg: $3.96
Low: $3.71
High: $4.04
avg. 17.49%
Avg: $4.4
Low: $4.11
High: $4.48
avg. 10.99%
Operating Expenses
 
% change YoY
$2.39B
 
N/A
$2.51B
 
4.83%
$3.09B
 
23.00%
Avg: $2.08B
Low: $2.05B
High: $2.11B
avg. -32.55%
Avg: $2.28B
Low: $2.17B
High: $2.31B
avg. 9.60%
Avg: $2.50B
Low: $2.38B
High: $2.54B
avg. 9.84%
Avg: $2.71B
Low: $2.57B
High: $2.75B
avg. 8.17%

FAQ

What is Edwards Lifesciences stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 17.96% in 2025-2028.

We have gathered data from 17 analysts. Their low estimate is 1.73B, average is 1.87B and high is 2.09B.

What is Edwards Lifesciences stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 11.91% in 2025-2028.

We have gathered data from 23 analysts. Their low revenue estimate is $7.11B, average is $7.20B and high is $7.32B.

What is Edwards Lifesciences stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 17.88% in 2025-2028.

We have gathered data from 17 analysts. Their low earnings per share estimate is $2.85, average is $3.11 and high is $3.43.

What is the best performing analyst?

In the last twelve months 11 analysts have been covering Edwards Lifesciences stock. The most successful analyst is William Plovanic.